New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 24, 2018, - The FDA approved Prograf (tacrolimus) granules for oral suspension, for the prophylaxis of organ rejection in patients receiving allogeneic liver, kidney or heart transplants, in combination with other immunosuppressants.
Download PDF
Return to publications
